Overview

Observational Study to Evaluate the Safety and Efficacy of Polyclonal Antibodies in Simultaneous Pancreas Kidney Transplant Recipients

Status:
Unknown status

Trial end date:
2021-03-01

Target enrollment:

Participant gender:

Summary

A single-centre, prospective, observational study to evaluate the safety and efficacy of Polyclonal Antibodies in simultaneous Pancreas Kidney Transplant recipients.

Phase:

Phase 4

Details

Lead Sponsor:

Tianjin First Central Hospital

Treatments:

Antibodies
Antilymphocyte Serum
Pancreatin
Pancrelipase